EUVIMEDEUVIMED entdecken
Crossref

Contrast-enhanced ultrasound findings are associated with tumor viability and depth of response in selected patients with unresectable hepatocellular carcinoma treated with immunotherapy-based combination therapy

Naoki Matsumoto, Masahiro Ogawa, Aya Konishi, Mai Totsuka, Tomohiro Kaneko, Masayuki Honda, Shuhei Arima, Yukinobu Watanabe, Ryota Masuzaki, Hirofumi Kogure

Journal of Medical Ultrasonics · 30.06.2026

DOI: 10.1007/s10396-026-01665-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Ultrasonics, online erschienen am 30.06.2026. Verfasst von Naoki Matsumoto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi Kamimachi, Itabashi-ku, Tokyo…. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Accurate evaluation of tumor viability during immunotherapy for unresectable hepatocellular carcinoma (HCC) remains challenging using contrast-enhanced computed tomography or magnetic resonance imaging (CECT/CEMRI), particularly after treatment-induced vascular changes. This exploratory study investigated whether contrast-enhanced ultrasound (CEUS) detects residual intratumoral perfusion differently from CECT/CEMRI and whether CEUS perfusion patterns are associated with depth of response (DpR) in selected patients receiving immunotherapy-based combination therapy.

Methods

Twenty-five patients with unresectable HCC treated with atezolizumab plus bevacizumab, durvalumab plus tremelimumab, or nivolumab plus ipilimumab who underwent both CEUS and CECT/CEMRI within a 3-month interval were retrospectively analyzed. CEUS was performed at a median of 33 days after treatment initiation. Arterial-phase enhancement patterns were classified as hyper-, iso-, or hypoenhancement relative to surrounding liver parenchyma. Tumor response was evaluated using RECIST version 1.1 and modified RECIST. DpR was defined as the maximum percentage reduction in tumor size from baseline.

Results

CEUS demonstrated hyperenhancement in 14 lesions compared with six lesions on CECT/CEMRI. Enhancement patterns were discordant in 13 cases, with CEUS demonstrating hyperenhancement in 10 lesions classified as iso- or hypoenhancement on CECT/CEMRI (p = 0.049). Tumor size reduction did not differ significantly among enhancement categories on CECT/CEMRI (p = 0.325), whereas CEUS enhancement patterns were significantly associated with DpR (p = 0.008).

Conclusion

In selected patients with unresectable HCC undergoing immunotherapy-based therapy, CEUS detected residual intratumoral perfusion more frequently than CECT/CEMRI and was significantly associated with DpR. CEUS may provide complementary information for exploratory assessment of tumor viability in this setting.

Schlagwörter

Stichwörter der Autor:innen

Contrast-enhanced ultrasoundDepth of responseHepatocellular carcinomaImmunotherapyResponse evaluation

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi Kamimachi, Itabashi-ku, Tokyo, 173-8610, Japan. matsumotosg@yahoo.co.jp.
  • Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi Kamimachi, Itabashi-ku, Tokyo, 173-8610, Japan.

Zitieren

APA

Matsumoto, N., Ogawa, M., Konishi, A., Totsuka, M., Kaneko, T., Honda, M., Arima, S., Watanabe, Y., Masuzaki, R., & Kogure, H. (2026). Contrast-enhanced ultrasound findings are associated with tumor viability and depth of response in selected patients with unresectable hepatocellular carcinoma treated with immunotherapy-based combination therapy. Journal of Medical Ultrasonics. https://doi.org/10.1007/s10396-026-01665-1

Vancouver

Matsumoto N, Ogawa M, Konishi A, Totsuka M, Kaneko T, Honda M, et al. Contrast-enhanced ultrasound findings are associated with tumor viability and depth of response in selected patients with unresectable hepatocellular carcinoma treated with immunotherapy-based combination therapy. Journal of Medical Ultrasonics. 2026. doi:10.1007/s10396-026-01665-1

BibTeX
@article{Matsumoto2026,
  author = {Matsumoto, Naoki and Ogawa, Masahiro and Konishi, Aya and Totsuka, Mai and Kaneko, Tomohiro and Honda, Masayuki and Arima, Shuhei and Watanabe, Yukinobu and Masuzaki, Ryota and Kogure, Hirofumi},
  title = {Contrast-enhanced ultrasound findings are associated with tumor viability and depth of response in selected patients with unresectable hepatocellular carcinoma treated with immunotherapy-based combination therapy},
  journal = {Journal of Medical Ultrasonics},
  year = {2026},
  doi = {10.1007/s10396-026-01665-1}
}
Kostenlos starten →